Protagonist Therapeutics, Inc Due to Related Parties, Current
Protagonist Therapeutics, Inc (PTGX) had Due to Related Parties, Current of $10.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-08-03
- 2023-06-30: Due to Related Parties, Current $10.00K.
- 2023-03-31: Due to Related Parties, Current $22.00K.
- 2022-12-31: Due to Related Parties, Current $69.00K.
- 2022-09-30: Due to Related Parties, Current $32.00K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2023-06-30 | $10.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $22.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $69.00K 10-Q · filed 2023-08-03 |
| 2022-09-30 | $32.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $80.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $380.00K 10-Q · filed 2023-05-04 |
| 2021-12-31 | $899.00K 10-Q · filed 2023-05-04 |
| 2021-09-30 | $1.12M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $11.40M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $6.82M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $2.73M 10-K · filed 2022-02-28 |
| 2020-09-30 | $2.08M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $1.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.12M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.26M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.02M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $810.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.21M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.06M 10-K · filed 2020-03-10 |
| 2018-09-30 | $764.00K 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |